Keyword Connections

bevacizumab

Journals

6

1 japanese journal of clinical oncology

2 Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners

3 journal of community hospital internal medicine perspectives

4 science (new york, ny)

5 gynecologie, obstetrique, fertilite & senologie

6 translational lung cancer research

Research Groups

0

No Research Group Connected

Bibliographies

56

1 [Medical treatment in ovarian cancers newly diagnosed: Article drafted from the French Guidelines in oncology entitled "Initial management of patients with epithelial ovarian cancer" developed by FRANCOGYN, CNGOF, SFOG, GINECO-ARCAGY under the aegis of CNGOF and endorsed by INCa].

2 Pharmaceutical diversification via palladium oxidative addition complexes.

3 A severe case of bevacizumab-induced thrombotic microangiopathy.

4 Posterior reversible encephalopathy syndrome (PRES) after bevacizumab therapy for metastatic colorectal cancer.

5 Safety and effectiveness of bevacizumab in Japanese patients with malignant glioma: a post-marketing surveillance study.

6 Open-label, multicenter, randomized phase II study on docetaxel plus bevacizumab or pemetrexed plus bevacizumab for treatment of elderly (aged ≥75 years) patients with previously untreated advanced non-squamous non-small cell lung cancer: TORG1323.

7 Factors Associated with Adverse Cardiovascular Events in Cancer Patients Treated with Bevacizumab

8 all india ophthalmological society members' survey: practice pattern of intravitreal anti-vascular endothelial growth factor injection

9 spectral domain optical coherence tomography morphology in optic disc pit associated maculopathy

10 loop myopexy with true muscle transplantation for very large angle heavy eye syndrome patient

11 shedding of bevacizumab in tumour cells-derived extracellular vesicles as a new therapeutic escape mechanism in glioblastoma

12 use of a combination of Аvastin and low-dose interferon- α in the first-line treatment of metastatic renal-cell cancer

13 combined special capsular tension ring and toric iol implantation for management of post-dalk high regular astigmatism with subluxated traumatic cataract

14 erratum: how to make the ghosts in my bedroom disappear? focused-attention meditation combined with muscle relaxation (mr therapy) — a direct treatment intervention for sleep paralysis

15 circulating biomarkers in advanced colorectal cancer patients randomly assigned to three bevacizumab-based regimens

16 utilización del bevacizumab en la neovascularización corneal use of bevacizumab in corneal neovascularization

17 metastatic renal cell carcinoma: a guide to therapy based on current evidence

18 an unusual case of self-inflicted multiple needles injuries to eye

19 immediate sequential bilateral intravitreal injections: an indian perspective

20 spectral domain optical coherence tomography features of multiple subfoveal retinal pigment epithelial tears after intravitreal bevacizumab

21 Ranibizumab versus bevacizumab to treat neovascular age-related macular degeneration: one-year findings from the IVAN randomized trial.

22 Evaluation of the Effect of Repeated Intravitreal Bevacizumab Injections on the Macular Microvasculature of a Diabetic Patient Using Optical Coherence Tomography Angiography

23 Bevacizumab Demonstrates Prolonged Disease Stabilization in Patients with Heavily Pretreated Metastatic Renal Cell Carcinoma: A Case Series and Review of the Literature

24 [Fluorescence Angiography-assisted Management of Recurrences in Aggressive Posterior Retinopathy of Prematurity (APROP) after Intravitreal Monotherapy with 0.312 mg Bevacizumab].

25 [Bevacizumab and invasive procedures: practical recommendations].

26 Clinical Effectiveness of Intravitreal Therapy With Ranibizumab vs Aflibercept vs Bevacizumab for Macular Edema Secondary to Central Retinal Vein Occlusion: A Randomized Clinical Trial.

27 A randomized controlled phase III study of VB-111 combined with bevacizumab vs. bevacizumab monotherapy in patients with recurrent glioblastoma (GLOBE).

28 The prognostic role of inflammatory markers in patients with metastatic colorectal cancer treated with bevacizumab: A translational study [ASCENT].

29 Efficacy of Intravitreal Bevacizumab in Treatment of Proliferative Type 2 Idiopathic Juxtafoveal Telangiectasia

30 Intravitreal Bevacizumab in Neovascular Age-Related Macular Degeneration as First Choice: a New Italian Ruling

31 Dramatic Resolution of Recalcitrant Cystoid Macular Edema after Concurrent Intravitreal Injection of Bevacizumab and Triamcinolone

32 intravitreal ranibizumab and bevacizumab for the treatment of nonsubfoveal choroidal neovascularization in age-related macular degeneration ranibizumab e bevacizumab intravítreo no tratamento da neovascularização de coróide extrafoveal da degeneração macular relacionada à idade

33 intravitreal bevacizumab in aggressive posterior retinopathy of prematurity

34 treatment of corneal neovascularization using anti-vegf bevacizumab

35 intravitreal bevacizumab in nonarteritic anterior ischemic optic neuropathy

36 diabetic papillopathy with macular edema treated with intravitreal bevacizumab

37 bevacizumab inhibits proliferation of choroidal endothelial cells by regulation of the cell cycle

38 new prognostic biomarkers and therapeutic effect of bevacizumab for patients with non-small-cell lung cancer

39 use of intravitreal bevacizumab or triamcinolone acetonide as a preoperative adjunct to vitrectomy for vitreous haemorrhage in diabetics injeção intravítrea de bevacizumabe ou triancinolona como adjuvantes da vitrectomia posterior no tratamento da hemorragia vítrea em diabéticos

40 bevacizumab for patients with recurrent gliomas presenting with a gliomatosis cerebri growth pattern

41 photopsias during systemic bevacizumab therapy

42 retro-mode imaging of fibrovascular membrane in proliferative diabetic retinopathy after intravitreal bevacizumab injection

43 sd-oct morphological changes in wet age-related macular degeneration patients after bevacizumab treatment

44 a comparative debate on the various anti-vascular endothelial growth factor drugs: pegaptanib sodium (macugen), ranibizumab (lucentis) and bevacizumab (avastin)

45 successful treatment of neovascular age-related macular degeneration following single bevacizumab failure using aflibercept in a vitrectomized eye

46 antiproliferative, apoptotic, and autophagic activity of ranibizumab, bevacizumab, pegaptanib, and aflibercept on fibroblasts: implication for choroidal neovascularization

47 cluster endophthalmitis following multiple intravitreal bevacizumab injections from a single use vial

48 conversion to aflibercept for diabetic macular edema unresponsive to ranibizumab or bevacizumab

49 bevacizumab and weekly docetaxel in patients with metastatic castrate-resistant prostate cancer previously exposed to docetaxel

50 rapid regression of retinal neovascularization following intravitreal bevacizumab in branch retinal vein occlusion imaged by optical coherence tomography angiography

51 bevacizumab for advanced ovarian cancer treatment. a grade based approach

52 a case report of long term bevacizumab treatment in multiresistant ovarian cancer

53 current status of bevacizumab in advanced ovarian cancer

54 intravitreal bevacizumab (avastin) for the treatment of proliferative sickle retinopathy

55 takotsubo cardiomyopathy in two men receiving bevacizumab for metastatic cancer

56 Does Neoadjuvant Bevacizumab Increase Surgical Complications in Breast Surgery?